[{"Assets_0_Q1_USD":2752422000.0,"CommonStockSharesConverted_0_Q1_shares":216952325.0,"CommonStockSharesOutstanding_0_Q1_shares":216952325.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-683417000.0,"NetIncomeLossConverted_1_Q1_USD":-720642000.0,"RevenuesConverted_1_Q1_USD":568507000.0,"StockholdersEquity_0_Q1_USD":1937721000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":216721000.0,"EarningsPerShareBasic_1_Q1_USD":-3.33,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":216721000.0,"EarningsPerShareDiluted_1_Q1_USD":-3.33,"Ticker":"INCY","CIK":"879169","name":"INCYTE CORP","OfficialName":"Incyte Corp. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17588712770.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"SP500","filed":"20200505"}]